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Malaria Control and
Public Health
To the Editor: Malaria continues
to cause disease and death in millions
of persons living in areas of the world
where it is endemic, despite 4 decades
of research on vaccines, new drugs,
and alternative methods of control.
Still, by far the most effective method
for reducing and controlling the
impact of this disease is indoor resid-
ual spraying (IRS) of insecticides.
The most cost-effective and safe
insecticide has been, and in many
instances still is, dichlorodiphenyl-
trichloroethane (DDT). This interven-
tion is continually under scrutiny, and
we address these issues in this letter.
Chen and Rogan (1) claim that
DDT causes reduced duration of lac-
tation and increased incidence of
preterm births, and they posit that
DDT used for malaria control would
do as much harm as good. The valid-
ity of their arguments requires sub-
stantial evidence of a causal relation-
ship between DDT and adverse con-
sequences of DDT IRS for malaria
control. 
Chen and Rogan dismiss a field
study on births and duration of lacta-
tion in South African mothers, some
of whom occupied houses sprayed
with DDT for malaria control (2).
However, if claims of large numbers
of adverse health effects of DDT IRS
are correct, then the study should have
detected large differences between
DDT-exposed and unexposed popula-
tions. According to Chen and Rogan,
the median duration of breastfeeding
could be as low as 3–4 months when
mothers are exposed to high levels of
DDT. Thus, a cross-section of breast-
feeding infants in the DDT-exposed
population should, on average, have
been considerably younger than in the
unexposed population. In fact, the
average age of breastfeeding infants
was slightly greater in the DDT-
exposed population (8.3 months ver-
sus 7.7 months). For both populations,
only an insignificant fraction of moth-
ers could not donate milk.
Furthermore, twice the level of
dichlordiphenylethylene (DDE, meta-
bolic breakdown product of DDT)
that is claimed to cause reduced dura-
tion of lactation in humans has no
adverse affect on lactation in rats (3).
The authors of the South African
study (2) report no difference in rates
of stillbirths between the sprayed and
unsprayed areas.
The National Institute of Environ-
mental Health Sciences study (4)
reported a causal association between
DDT and preterm and small-for-ges-
tational-age births but this has not
been replicated for African births.
The study was not based on a random
population of births, and no explana-
tion is offered for including diverse
categories of births in the study pop-
ulation.
An earlier study in Sri Lanka pre-
sented data on deaths attributed to
malaria and to premature births years
before DDT was used and years when
DDT IRS was used in 21 districts (5).
Districts varied greatly in levels of
malaria endemicity. After DDT was
introduced in 1946, levels of IRS in
21 districts were commensurate with
levels of endemic malaria. After 1946,
malaria deaths declined greatly and
the reduction was greatest where
DDT usage was highest. During the
same period, deaths attributable to
premature births increased slightly.
Inves-tigators attributed this to
“improvements in reporting and diag-
nosis rather than any declines in the
health of expectant mothers, which on
all other criteria showed improve-
ment.” (5). Spearman’s correlation
analysis for 21 districts shows that the
increase in premature birth deaths was
slightly greater in areas with less
malaria and DDT use. Thus, the evi-
dence does not support the idea that
the reported increase in premature
births was a side effect of DDT use. In
any case, the increase in deaths attrib-
utable to premature births was orders
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of magnitude less than the reduction
in deaths directly caused by malaria
and other conditions indirectly related
to malaria (5).
Similar major benefits of DDT use
were seen in Guyana, where in 2 to 3
years, near elimination of malaria
halved maternal deaths and reduced
infant deaths by 39% (6). Anemia-
associated deaths in pregnant females
were reduced from 10 to 2.3 per 1,000
adult deaths (7). There was no offset
of infant deaths attributable to adverse
effects of DDT. Data from Guyana are
particularly relevant to the present
issue because malaria control was
entirely due to DDT, i.e., drug treat-
ments were not included (7). Health
improvements related to DDT use
accounted for 21% to 56% of
increased population growth in
Guyana during the postwar years (5).
In summary, these data from South
Africa, Sri Lanka, and Guyana are
clearly contrary to the claims of Chen
and Rogan (1) that ill effects of DDT
on maternal health and infant survival
would counterbalance the beneficial
effect of malaria control. Their claim
that alternative chemicals are cheaper
than DDT is incorrect (8). Recent data
on pyrethroid-treated bed nets are
encouraging for situations in which
sustained provision of spray pumps
and trained spray teams are not feasi-
ble. However, even the best results
with these nets do not match those
obtained in the past with IRS, e.g., the
suppression of malaria infection in
Zanzibar from holoendemic levels to
<5% (9). 
In recent years, programs in South
Africa and Madagascar (10) that
again started IRS with DDT have
greatly reduced malaria and malaria-
related deaths. DDT is still needed
and research is required to improve its
use. The Stockholm Convention on
Persistent Organic Pollutants specifi-
cally allows continued public health
use of DDT.
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In Reply: We do not believe that
causality has been demonstrated for
the relationship between dichlor-
diphenylethylene (DDE) and shorter
period of lactation or preterm birth.
However, we think the evidence is
sufficiently strong that the possibility
of causality cannot be dismissed and
testing this hypothesis will require
data from appropriately designed
studies in areas where dichloro-
diphenyltrichloroethane (DDT) is
used. 
We think that the cross-sectional
study (1) referred to by Roberts et al.
(2) cannot determine whether DDE
shortens lactation. Women with high-
er levels of DDE and shorter lactation
periods would be less likely than
women with lower levels of DDE and
longer lactation periods to appear in
such a study, which would mask any
associations.
As noted in the Longnecker report
on the association between DDE and
preterm birth (3), several previous
studies have shown such an effect, but
they were relatively small. That the
perinatal collaborative study was not
a random sample of U.S. births does
not seem relevant. Women could not
choose whether to participate on the
basis of their DDT level because they
did not know it and could not choose
whether to participate on the basis of
a preterm birth because they were
enrolled during pregnancy.
Roberts et al. reference success
stories of DDT use from the 1930s to
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